205 related articles for article (PubMed ID: 36688997)
1. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma.
Zhao F; Tian H; Wang Y; Zhang J; Liu F; Fu L
Cancer Immunol Immunother; 2023 Jun; 72(6):1835-1851. PubMed ID: 36688997
[TBL] [Abstract][Full Text] [Related]
2. Tumor associated macrophages in esophageal squamous carcinoma: Promising therapeutic implications.
Zhang J; Dong Y; Di S; Xie S; Fan B; Gong T
Biomed Pharmacother; 2023 Nov; 167():115610. PubMed ID: 37783153
[TBL] [Abstract][Full Text] [Related]
3. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
4. Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer.
Chang J; Feng Q; Mao Y; Zhang Z; Xu Y; Chen Y; Zheng P; Lin S; Shen F; Zhang Z; Zhang Z; He G; Xu J; Wei Y
Int Immunopharmacol; 2024 Mar; 130():111771. PubMed ID: 38430807
[TBL] [Abstract][Full Text] [Related]
5. HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma.
Yuan X; Liu K; Li Y; Zhang AZ; Wang XL; Jiang CH; Liang WH; Zhang HJ; Pang LJ; Li M; Yang L; Qi Y; Zheng Q; Li F; Hu JM
Clin Transl Oncol; 2021 Nov; 23(11):2382-2393. PubMed ID: 34075547
[TBL] [Abstract][Full Text] [Related]
6. ANXA10 induction by interaction with tumor-associated macrophages promotes the growth of esophageal squamous cell carcinoma.
Kodaira H; Koma YI; Hosono M; Higashino N; Suemune K; Nishio M; Shigeoka M; Yokozaki H
Pathol Int; 2019 Mar; 69(3):135-147. PubMed ID: 30758105
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
[TBL] [Abstract][Full Text] [Related]
8. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
9. Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.
Wu H; Yu J; Kong D; Xu Y; Zhang Z; Shui J; Li Z; Luo H; Wang K
Int J Oncol; 2019 Dec; 55(6):1237-1248. PubMed ID: 31638164
[TBL] [Abstract][Full Text] [Related]
10. Similarities between wound re-epithelialization and Metastasis in ESCC and the crucial involvement of macrophages: A review.
Chabeli MS; Wang X; Yinghao L; Chen C; Yang C; Shou Y; Wang S; Chen K
Cancer Treat Res Commun; 2022; 32():100621. PubMed ID: 36007473
[TBL] [Abstract][Full Text] [Related]
11. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma.
Yang K; Xie Y; Xue L; Li F; Luo C; Liang W; Zhang H; Li Y; Ren Y; Zhao M; Wang W; Liu J; Shen X; Zhou W; Fei J; Chen W; Gu W; Wang L; Li F; Hu J
J Transl Med; 2023 Jan; 21(1):26. PubMed ID: 36641471
[TBL] [Abstract][Full Text] [Related]
12. Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase.
Mai S; Liu L; Jiang J; Ren P; Diao D; Wang H; Cai K
Cell Prolif; 2021 Feb; 54(2):e12960. PubMed ID: 33305406
[TBL] [Abstract][Full Text] [Related]
13. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563
[TBL] [Abstract][Full Text] [Related]
14. Infiltrated M2 tumour-associated macrophages in the stroma promote metastasis and poor survival in oesophageal squamous cell carcinoma.
Zhou J; Zheng S; Liu T; Liu Q; Chen Y; Ma R; Tan D; Lu X
Histol Histopathol; 2019 May; 34(5):563-572. PubMed ID: 30417922
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
16. Software-assisted morphometric and phenotype analyses of human peripheral blood monocyte-derived macrophages induced by a microenvironment model of human esophageal squamous cell carcinoma.
Nishio M; Urakawa N; Shigeoka M; Takase N; Ichihara Y; Arai N; Koma Y; Yokozaki H
Pathol Int; 2016 Feb; 66(2):83-93. PubMed ID: 26778807
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor erythroid 2-related factor 2 promotes radioresistance by regulating glutamate-cysteine ligase modifier subunit and its unique immunoinvasive pattern.
Xue Z; Nuerrula Y; Sitiwaerdi Y; Eli M
Biomol Biomed; 2024 May; 24(3):545-559. PubMed ID: 38340316
[TBL] [Abstract][Full Text] [Related]
18. P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro.
Wang X; Wei S; Li W; Wei X; Zhang C; Dai S; Ma M; Zhao L; Shan B
Int Immunopharmacol; 2023 Jun; 119():110213. PubMed ID: 37137266
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis.
Chen J; Zhao D; Zhang L; Zhang J; Xiao Y; Wu Q; Wang Y; Zhan Q
Drug Resist Updat; 2024 Mar; 73():101055. PubMed ID: 38387281
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-23 receptor signaling mediates cancer dormancy and radioresistance in human esophageal squamous carcinoma cells via the Wnt/Notch pathway.
Zhou Y; Su Y; Zhu H; Wang X; Li X; Dai C; Xu C; Zheng T; Mao C; Chen D
J Mol Med (Berl); 2019 Feb; 97(2):177-188. PubMed ID: 30483821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
